Tharimmune Investor Relations Material

Tharimmune Inc. is a biopharmaceutical company focused on the development of immune-modulating therapies for inflammatory diseases and cancer. The company specializes in small molecule and biologic drug candidates designed to regulate immune responses and target disease pathways. Tharimmune conducts clinical research and drug development to address unmet medical needs in autoimmune disorders, oncology, and fibrosis-related conditions. The company is headquartered in Westlake Village, California, and its shares are listed on the NASDAQ.